Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 204,765 |
|
|||||
| News | - | ||||||
| Day High | 2.485 | Low High |
|||||
| Day Low | 2.27 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Regulus Therapeutics Inc | RGLS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.15 | 6.61% | 2.42 | 17:06:33 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.30 | 2.27 | 2.485 | 2.42 | 2.27 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,822 | 204,765 | US$ 2.41 | US$ 493,468 | - | 1.08 - 3.78 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 5,521 | US$ 2.42 | USD |
Regulus Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 48.74M | 20.22M | - | 0 | -30.04M | -1.49 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Regulus Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGLS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.23 | 2.485 | 2.09 | 2.20 | 128,190 | 0.19 | 8.52% |
| 1 Month | 2.90 | 2.91 | 2.09 | 2.61 | 315,821 | -0.48 | -16.55% |
| 3 Months | 1.32 | 3.78 | 1.2724 | 2.38 | 3,326,889 | 1.10 | 83.33% |
| 6 Months | 1.31 | 3.78 | 1.08 | 2.37 | 1,557,189 | 1.11 | 84.73% |
| 1 Year | 1.39 | 3.78 | 1.08 | 2.35 | 788,523 | 1.03 | 74.10% |
| 3 Years | 1.40 | 3.78 | 0.1576 | 1.10 | 1,124,965 | 1.02 | 72.86% |
| 5 Years | 1.12 | 3.78 | 0.1576 | 1.17 | 1,186,692 | 1.30 | 116.07% |
Regulus Therapeutics Description
| Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes. |
